In April, Aier Hospital Group introduced a heavyweight specialist in fundus and difficult eye diseases, Professor Peng Xiaoyan, who will be the Vice President of Aier Beijing SAR. From April 14, Prof. Peng Xiaoyan will be at Beijing AIER Intech Eye Hospital.

A life of dedication in white

As a senior ophthalmologist in China, Prof. Peng Xiaoyan has been dedicated to clinical and basic research on fundus diseases for many years and has rich clinical experience in the diagnosis and treatment of fundus diseases, specializing in the analysis and diagnosis of difficult ophthalmic diseases and comprehensive treatment of complex ophthalmic diseases. She has deep attainments in basic and clinical research of fundus vascular diseases and molecular pathology of retinal degeneration, and is one of the leading experts in fundus fluorescence angiography reading, laser treatment of fundus diseases, and vitreous and retinal surgery.

Prof. Peng is the deputy head of the Ocular Immunology Group of the Chinese Medical Association Ophthalmology Branch, a member of the Beijing Medical Association Ophthalmology Branch, the head of the Drug Therapy Group of the Chinese Physicians' Association Ophthalmology Branch, an editorial board member of the Chinese Journal of Ophthalmology, the Chinese Journal of Fundus Diseases, and the Journal of Ophthalmology, and has published more than 160 papers in English and Chinese as the first author and corresponding author in the field of fundus diseases. As a Ph.

As a doctoral supervisor, Prof. Peng Xiaoyan has trained a number of excellent ophthalmology talents. Aier Hospital Group attaches great importance to clinical, scientific research and talent training in ophthalmology, and through a mature integrated development model of medical education and research, we have pooled our efforts to tackle difficult eye diseases. At the same time, Aier Hospital Group has more than 800 professional ophthalmology institutions around the world, which cover different races, genders, age groups, and different regions in Asia, America, and Europe, which is a solid foundation for large-scale, multi-center research. We hope that after joining Aier Hospital Group, we can work together with all our colleagues in Aier Hospital Group Beijing to seek higher breakthroughs in clinical, scientific research and academics for the benefit of more eye disease patients.

Professor Li Shaowei, Director of the Institute of Cornea Disease and CEO of Beijing AIER Intech Eye Hospital， expressed a warm welcome to Professor Peng on behalf of the Beijing District, "Professor Peng's arrival has given a strong impetus to the high-quality development of Aier Hospital Group Beijing SAR, which will further increase the benefit of high-quality medical resources to the people. I hope that in this new platform, Professor Peng will play a full role in all aspects of medical education and research, and work together with us for the cause of people's eye health."

Professor Wang Zhijun, Vice President of Aier Hospital Group Beijing SAR, said that Professor Peng's excellent medical skills, moral and talent, and her reputation among patients and peers alike, will further drive the overall medical service capacity of Aier Hospital Group Beijing SAR and bring light and hope to more eye patients.

"I believe that under the leadership of Professor Peng and the experts, the hospital will see a major breakthrough in the diagnosis and treatment of fundus diseases and difficult eye diseases." said President Gu Wei, deputy head of the Fundus Disease Group of Aier Hospital Group and the leader of the Fundus Disease Department of Beijing AIER Intech Eye Hospital.